| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |